1Writing Committee of the Second World Health Organization Consultation on Clinical Aspects of Human Infection with Avian Influenza A (H5N1) Virus. Update on avian Influenza A (H5N1) virus infection in humans[J]. N Engl J Med, 2008, 358(3) ;261-273.
2Schunemann H J, Hill SR, Kakad M, et al. WHO Rapid Advice Guidelines for pharmacological management of sporadic human infection with avian influenza A (H5N1) virus[J]. Lancet Infect Dis,2007,7(1) :21-31.
3Ungehusak K, Auewarakul P, Dowell SF, et al. Probable person-to-person transmission of avian influenza A (HSN1) [J]. N Engl J Med, 2005,352(4) :333-340.
4Normile D. Avian influenza. Human transmission but no pandemic in Indonesia [J]. Science, 2006,312(5782) :1855.
5Gu J,Xie Z, Gao Z, et al. H5N1 infection of the respiratory tract and beyond: a molecular pathology study [J]. Lancet, 2007,370 (9593) :1137-1145.
6Miller LG,Perdreau-Remington F,Bayer AS,et al. Clinical and epidemiologic characteristics cannot distinguish community-associated methicillin-resistant Staphylococcus aureus infection from methicillin-susceptible S. aureus infection: a prospective investigation[J]. Clin Infect Dis,2007,44(4) :471-482.
8Maartens G ,Wilkinson RJ, Tuberculosis[J]. Lancet, 2007,370 (9604) :2030-2043.
9Basu S, Andrews JR, Poolman EM, et al. Prevention of nosocomial transmission of extensively drug-resistant tuberculosis in rural South African district hospitals: an epidemiological modelling study[J]. Lancet,2007,370 (9597) : 1500-1507.
10Rossolini GM, Mantengoli E, Docquier JD, et al. Epidemiology of infections caused lay multiresistartt gram-negatives: ESBLs, MBLs, panresistant strains [J]. New Microbiol, 2007,30 (3) : 332-339.
3Ascioglu S, Rex JH, de Pauw B, et al. Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus. Clin Infect Dis, 2002, 34: 7-14.
4Bohme A, Ruhnke M, Buchheidt D, et al. Treatment of fungal infections in hematology and oncology-guidelines of the Infectious Diseases Working Party (AG1HO) of the German Society of Hematology and Oncology (DGHO). Ann Hematol, 2003, 82 Suppl 2 :S133-S140.
